Government

WHITE PAPERS AND CASE STUDIES

• The Evolution Of Antibody-Drug Manufacturing

  Explore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.

• FDA Recommendations For Gene Therapy For PMDs

  Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).

• Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection

  Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.

• Selecting The Optimal Blower For The Water Industry

  In this white paper, we will drill down into which technology has particularly proven itself in terms of energy efficiency in the water industry.

• Cell And Gene Therapy Field Quiet In Q2

  While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.

• UV Water Treatment Plants For Microorganism Prevention

  Recognizing the urgent need to ensure safe drinking water, the Queenstown Lakes District Council in New Zealand partnered with FILTEC to implement advanced UV water treatment solutions across key plants.

• Pittsburgh Water Sets New Standard With Customer Request Sampling To Support Lead Service Line Replacement

  Discover how 120Water helped Pittsburgh Water reduce their turnaround times, streamline sampling workflows, and save hours of work. Learn how you can also use sampling to support your replacement and community engagement programs with their case study.

• Design Testing Strategies To Develop A Drug-Device Combination Product

  Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.

• Understanding Biosafety Levels

  Compliance with biosafety levels (BSLs) is crucial in ensuring that your laboratories meet stringent standards to protect staff and prevent the escape of biological agents.

• Incremental Adoption Of A Modular Operations Platform

  Discover the potential of a modular operations platform that scales the benefits of digitalization and aids organizations in implementing a unified data strategy to realize the full potential of smart manufacturing.

• Building A Legacy In Sterile Injectables Through Strong CMO Synergy

  Examine how a CMO can deliver significant value to drug developers by fostering successful outsourcing relationships, streamlining the path to market, and supporting demands.

• How To Get Products To Patients Faster With A Connected QMS

  BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Discover how digital solutions streamlined their operations and improved regulatory efficiency.